Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop
Extrapolation from adults to youth with type 2 diabetes (T2D) is challenged by differences in disease progression and manifestation. This manuscript presents the results of a mock‐team workshop focused on examining the typical team‐based decision process used to propose a pediatric development plan...
Gespeichert in:
Veröffentlicht in: | Clinical pharmacology and therapeutics 2020-07, Vol.108 (1), p.29-39 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 39 |
---|---|
container_issue | 1 |
container_start_page | 29 |
container_title | Clinical pharmacology and therapeutics |
container_volume | 108 |
creator | Barrett, Jeffrey S. Bucci‐Rechtweg, Christina Amy Cheung, S. Y. Gamalo‐Siebers, Margaret Haertter, Sebastian Karres, Janina Marquard, Jan Mulugeta, Yeruk Ollivier, Cecile Strougo, Ashley Yanoff, Lisa Yao, Lynne Zeitler, Philip |
description | Extrapolation from adults to youth with type 2 diabetes (T2D) is challenged by differences in disease progression and manifestation. This manuscript presents the results of a mock‐team workshop focused on examining the typical team‐based decision process used to propose a pediatric development plan for T2D addressing the viability of extrapolation. The workshop was held at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Orlando, Florida on March 21, 2018. |
doi_str_mv | 10.1002/cpt.1805 |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7383960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CPT1805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3775-d0dc2eec8d90b513e13d93e31eff10986e1fbd05caeb2e783ce84a9cba00c0d53</originalsourceid><addsrcrecordid>eNp1kE1PwzAMhiMEYuND4hegHLl0OM3SDw5IaGwwaYgdhjhGaeKyQNdUTQfs39NtMMGBk2X58WPrJeSMQY8BhJe6anosAbFHukzwMIgEF_ukCwBpkIY86pAj71_btp8mySHp8BBYDH3eJQ9TNFY1tdV0-NnUqnKFaqwrqS3pbFUhDemtVRk26K_oaNksa6TjRVVYvcE8dTlV9NnVb37uqhNykKvC4-l3PSZPo-FscB9MHu_Gg5tJoHkci8CA0SGiTkwKmWAcGTcpR84wzxmkSYQszwwIrTALMU64xqSvUp0pAA1G8GNyvfVWy2yBRmPZvl7IqrYLVa-kU1b-nZR2Ll_cu4x5wtMIWsHFVqBr532N-W6XgVxHKttI5TrSFj3_fWsH_mTYAsEW-LAFrv4VycF0thF-AZR-gik</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Barrett, Jeffrey S. ; Bucci‐Rechtweg, Christina ; Amy Cheung, S. Y. ; Gamalo‐Siebers, Margaret ; Haertter, Sebastian ; Karres, Janina ; Marquard, Jan ; Mulugeta, Yeruk ; Ollivier, Cecile ; Strougo, Ashley ; Yanoff, Lisa ; Yao, Lynne ; Zeitler, Philip</creator><creatorcontrib>Barrett, Jeffrey S. ; Bucci‐Rechtweg, Christina ; Amy Cheung, S. Y. ; Gamalo‐Siebers, Margaret ; Haertter, Sebastian ; Karres, Janina ; Marquard, Jan ; Mulugeta, Yeruk ; Ollivier, Cecile ; Strougo, Ashley ; Yanoff, Lisa ; Yao, Lynne ; Zeitler, Philip</creatorcontrib><description>Extrapolation from adults to youth with type 2 diabetes (T2D) is challenged by differences in disease progression and manifestation. This manuscript presents the results of a mock‐team workshop focused on examining the typical team‐based decision process used to propose a pediatric development plan for T2D addressing the viability of extrapolation. The workshop was held at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Orlando, Florida on March 21, 2018.</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1002/cpt.1805</identifier><identifier>PMID: 32017043</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Adolescent ; Adult ; Age Factors ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - physiopathology ; Disease Progression ; Education - methods ; Humans ; Hypoglycemic Agents - pharmacology ; White Paper</subject><ispartof>Clinical pharmacology and therapeutics, 2020-07, Vol.108 (1), p.29-39</ispartof><rights>2020 The Authors. published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.</rights><rights>2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3775-d0dc2eec8d90b513e13d93e31eff10986e1fbd05caeb2e783ce84a9cba00c0d53</citedby><cites>FETCH-LOGICAL-c3775-d0dc2eec8d90b513e13d93e31eff10986e1fbd05caeb2e783ce84a9cba00c0d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcpt.1805$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcpt.1805$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32017043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barrett, Jeffrey S.</creatorcontrib><creatorcontrib>Bucci‐Rechtweg, Christina</creatorcontrib><creatorcontrib>Amy Cheung, S. Y.</creatorcontrib><creatorcontrib>Gamalo‐Siebers, Margaret</creatorcontrib><creatorcontrib>Haertter, Sebastian</creatorcontrib><creatorcontrib>Karres, Janina</creatorcontrib><creatorcontrib>Marquard, Jan</creatorcontrib><creatorcontrib>Mulugeta, Yeruk</creatorcontrib><creatorcontrib>Ollivier, Cecile</creatorcontrib><creatorcontrib>Strougo, Ashley</creatorcontrib><creatorcontrib>Yanoff, Lisa</creatorcontrib><creatorcontrib>Yao, Lynne</creatorcontrib><creatorcontrib>Zeitler, Philip</creatorcontrib><title>Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Extrapolation from adults to youth with type 2 diabetes (T2D) is challenged by differences in disease progression and manifestation. This manuscript presents the results of a mock‐team workshop focused on examining the typical team‐based decision process used to propose a pediatric development plan for T2D addressing the viability of extrapolation. The workshop was held at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Orlando, Florida on March 21, 2018.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Disease Progression</subject><subject>Education - methods</subject><subject>Humans</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>White Paper</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kE1PwzAMhiMEYuND4hegHLl0OM3SDw5IaGwwaYgdhjhGaeKyQNdUTQfs39NtMMGBk2X58WPrJeSMQY8BhJe6anosAbFHukzwMIgEF_ukCwBpkIY86pAj71_btp8mySHp8BBYDH3eJQ9TNFY1tdV0-NnUqnKFaqwrqS3pbFUhDemtVRk26K_oaNksa6TjRVVYvcE8dTlV9NnVb37uqhNykKvC4-l3PSZPo-FscB9MHu_Gg5tJoHkci8CA0SGiTkwKmWAcGTcpR84wzxmkSYQszwwIrTALMU64xqSvUp0pAA1G8GNyvfVWy2yBRmPZvl7IqrYLVa-kU1b-nZR2Ll_cu4x5wtMIWsHFVqBr532N-W6XgVxHKttI5TrSFj3_fWsH_mTYAsEW-LAFrv4VycF0thF-AZR-gik</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Barrett, Jeffrey S.</creator><creator>Bucci‐Rechtweg, Christina</creator><creator>Amy Cheung, S. Y.</creator><creator>Gamalo‐Siebers, Margaret</creator><creator>Haertter, Sebastian</creator><creator>Karres, Janina</creator><creator>Marquard, Jan</creator><creator>Mulugeta, Yeruk</creator><creator>Ollivier, Cecile</creator><creator>Strougo, Ashley</creator><creator>Yanoff, Lisa</creator><creator>Yao, Lynne</creator><creator>Zeitler, Philip</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202007</creationdate><title>Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop</title><author>Barrett, Jeffrey S. ; Bucci‐Rechtweg, Christina ; Amy Cheung, S. Y. ; Gamalo‐Siebers, Margaret ; Haertter, Sebastian ; Karres, Janina ; Marquard, Jan ; Mulugeta, Yeruk ; Ollivier, Cecile ; Strougo, Ashley ; Yanoff, Lisa ; Yao, Lynne ; Zeitler, Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3775-d0dc2eec8d90b513e13d93e31eff10986e1fbd05caeb2e783ce84a9cba00c0d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Disease Progression</topic><topic>Education - methods</topic><topic>Humans</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>White Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barrett, Jeffrey S.</creatorcontrib><creatorcontrib>Bucci‐Rechtweg, Christina</creatorcontrib><creatorcontrib>Amy Cheung, S. Y.</creatorcontrib><creatorcontrib>Gamalo‐Siebers, Margaret</creatorcontrib><creatorcontrib>Haertter, Sebastian</creatorcontrib><creatorcontrib>Karres, Janina</creatorcontrib><creatorcontrib>Marquard, Jan</creatorcontrib><creatorcontrib>Mulugeta, Yeruk</creatorcontrib><creatorcontrib>Ollivier, Cecile</creatorcontrib><creatorcontrib>Strougo, Ashley</creatorcontrib><creatorcontrib>Yanoff, Lisa</creatorcontrib><creatorcontrib>Yao, Lynne</creatorcontrib><creatorcontrib>Zeitler, Philip</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barrett, Jeffrey S.</au><au>Bucci‐Rechtweg, Christina</au><au>Amy Cheung, S. Y.</au><au>Gamalo‐Siebers, Margaret</au><au>Haertter, Sebastian</au><au>Karres, Janina</au><au>Marquard, Jan</au><au>Mulugeta, Yeruk</au><au>Ollivier, Cecile</au><au>Strougo, Ashley</au><au>Yanoff, Lisa</au><au>Yao, Lynne</au><au>Zeitler, Philip</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2020-07</date><risdate>2020</risdate><volume>108</volume><issue>1</issue><spage>29</spage><epage>39</epage><pages>29-39</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><abstract>Extrapolation from adults to youth with type 2 diabetes (T2D) is challenged by differences in disease progression and manifestation. This manuscript presents the results of a mock‐team workshop focused on examining the typical team‐based decision process used to propose a pediatric development plan for T2D addressing the viability of extrapolation. The workshop was held at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Orlando, Florida on March 21, 2018.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>32017043</pmid><doi>10.1002/cpt.1805</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9236 |
ispartof | Clinical pharmacology and therapeutics, 2020-07, Vol.108 (1), p.29-39 |
issn | 0009-9236 1532-6535 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7383960 |
source | MEDLINE; Wiley Journals |
subjects | Adolescent Adult Age Factors Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - physiopathology Disease Progression Education - methods Humans Hypoglycemic Agents - pharmacology White Paper |
title | Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T01%3A39%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pediatric%20Extrapolation%20in%20Type%202%20Diabetes:%20Future%20Implications%20of%20a%20Workshop&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Barrett,%20Jeffrey%20S.&rft.date=2020-07&rft.volume=108&rft.issue=1&rft.spage=29&rft.epage=39&rft.pages=29-39&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1002/cpt.1805&rft_dat=%3Cwiley_pubme%3ECPT1805%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32017043&rfr_iscdi=true |